Reduced disease severity following therapeutic treatment with angiotensin 1-7 in a mouse model of multiple sclerosis.
Lund, B T; Stone, R; Levy, A M; Lee, S; Amundson, E; Kashani, N; Rodgers, K E; Kelland, E E.
; 127: 87-100, 2019 07.
Artigo em Inglês | MEDLINE | ID: mdl-30818065
Daclizumab en la esclerosis multiple.
Biomedical research in france and brazil: an analysis of significant differences and ethical issues